Julie E Ledgerwood

Julie E Ledgerwood

UNVERIFIED PROFILE

Are you Julie E Ledgerwood?   Register this Author

Register author
Julie E Ledgerwood

Julie E Ledgerwood

Publications by authors named "Julie E Ledgerwood"

Are you Julie E Ledgerwood?   Register this Author

65Publications

1826Reads

-Profile Views

Epitope-Specific Serological Assays for RSV: Conformation Matters.

Vaccines (Basel) 2019 Feb 23;7(1). Epub 2019 Feb 23.

Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/vaccines7010023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466065PMC
February 2019

Zika Virus Vaccine Development: Progress in the Face of New Challenges.

Annu Rev Med 2019 01 2;70:121-135. Epub 2018 Nov 2.

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA; email:

View Article

Download full-text PDF

Source
https://www.annualreviews.org/doi/10.1146/annurev-med-040717
Publisher Site
http://dx.doi.org/10.1146/annurev-med-040717-051127DOI Listing
January 2019

The Zika virus envelope protein glycan loop regulates virion antigenicity.

Virology 2018 02 2;515:191-202. Epub 2018 Jan 2.

Viral Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2017.12.032DOI Listing
February 2018

Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses.

Clin Nucl Med 2017 May;42(5):329-334

From the *Vaccine Research Center, National Institute of Allergy and Infectious Disease, †Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Disease, and ‡Positron Emission Tomography Department, Clinical Center, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001603DOI Listing
May 2017

Chimpanzee Adenovirus Vector Ebola Vaccine.

N Engl J Med 2017 03 26;376(10):928-938. Epub 2014 Nov 26.

From the Vaccine Research Center (J.E.L., A.D.D., D.A.S., E.E.C., L.N., M.E.E., N.M.B., A.P., S.S., I.J.G., S.A.P., L.A.H., C.S.H., G.Y., R.T.B., R.M.S., M.R., J.R.M., R.A.K., N.J.S., B.S.G.) and the Biostatistics Research Branch, Division of Clinical Research (Z.H., G.J.), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; GlaxoSmithKline Vaccines, Rixensart, Belgium (F.R.); ReiThera, Rome (A.N., S.C.), and CEINGE and the Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples (A.N.) - both in Italy; and Keires, Basel, Switzerland (R.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1410863DOI Listing
March 2017

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

N Engl J Med 2017 01 1;376(4):330-341. Epub 2015 Apr 1.

From the Walter Reed Army Institute of Research (J.A.R., K.M.P., A.R.C., J.E.M., R.C.R., J.W.B., P.S.T., S.A.R., H.R.H., M.S., L.L.J., S.A.P., N.L.M., S.J.T.) and Naval Medical Research Center (R.L.G.), Silver Spring, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research (J.H.B., W.J.), and the U.S. Army Medical Research Institute of Infectious Diseases (M.L.W., M.D.J., S.A.K., N.V.D., K.S.S., J.W.H., P.M.S.), Frederick, and the National Institute of Allergy and Infectious Diseases (NIAID) (J.V., Z.H., P.M., H.C.L., R.T.D.) and NIAID Vaccine Research Center (O.T.M., Y.Z., D.A.S., J.E.L., B.S.G., N.J.S.), Bethesda - all in Maryland; the Public Health Agency of Canada, Ottawa (J.B.A.); and BioProtection Systems-NewLink Genetics, Ames, IA (B.K.M., T.P.M., W.J.R., C.J.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1414216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408576PMC
January 2017

Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.

J Infect Dis 2016 Dec;214(suppl 5):S497-S499

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jiw352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137244PMC
December 2016

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.

N Engl J Med 2016 11 9;375(21):2037-2050. Epub 2016 Nov 9.

From the University of Pennsylvania (K.J.B., D.B.S., B.S., G.H.L., E.F.K., M.B., J.A.H., P.T.) and Children's Hospital of Philadelphia (N.B.T.) - both in Philadelphia; the Laboratory of Immunoregulation (M.C.S., J.S.J., M.E.P., J.B., E.W.R., K.E.C., S.M., A.S.F., T.-W.C.), Biostatistics Research Branch (M.A.P.), Vaccine Research Center (P.J.M., S.J.O., A.R.S., N.A.D.-R., R.T.B., J.E.L., R.M.L., B.S.G., R.A.K., J.R.M.), and Division of AIDS (R.L.T.), National Institute of Allergy and Infectious Diseases and National Institutes of Health (NIH), and the Critical Care Medicine Department, Clinical Center, NIH (C.A.S., R.W.K.), Bethesda, the AIDS Clinical Trials Group, Silver Spring (K.O.), and Columbus Technologies and Services, Greenbelt (R.L.T.) - all in Maryland; Harvard T.H. Chan School of Public Health, Boston (L.J.H.); the University of Alabama at Birmingham, Birmingham (E.T.O., M.M.); Frontier Science and Technology Research Foundation, Amherst, NY (B.J.); and the University of California, San Diego, La Jolla (E.V.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1608243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292134PMC
November 2016

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype.

Cell Rep 2016 08 29;16(6):1485-1491. Epub 2016 Jul 29.

Viral Pathogenesis Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.07.049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004740PMC
August 2016

Circulating CXCR5⁺CD4⁺ T Follicular-Like Helper Cell and Memory B Cell Responses to Human Papillomavirus Vaccines.

PLoS One 2015 2;10(9):e0137195. Epub 2015 Sep 2.

Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137195PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557948PMC
May 2016

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

N Engl J Med 2016 Apr 28;374(17):1635-46. Epub 2015 Jan 28.

From the Jenner Institute and Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford (K.E., T.R., N.V., G.B., D.W., T.L., E.B.I., R.P., C.M.T., N.J.E., G.L., J.J., M.G., A.M., M.W., I.P., N.L., R.R., F.H., C.B., K.S.-D., J.P., E.B., A.J.P., S.J.D., A.L., S.C.G., A.V.S.H.), and Viral Pseudotype Unit, Faculty of Science and Technology, University of Westminster (E.M.B., E.W.), and Virus Reference Department, Public Health Agency (D.S., R.T.), London - all in the United Kingdom; the Institute of Virology, Philipps University Marburg (S.K.F., T.S., N.B., V.K., S.B.), and German Center for Infection Research, Partner Site Giessen-Marburg-Langen (S.B.), Marburg, and Bavarian Nordic, Martinsried (A.V., P.C.) - all in Germany; GlaxoSmithKline Biologicals, Rixensart, Belgium (F.R., I.D.R., W.R.B.); ReiThera, Rome (A.N., L.S., S.C., A.F., S.D.M.), and CEINGE and the Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples (A.N.) - both in Italy; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda (N.J.S., D.A.S., O.T.M., J.E.L., R.M.S., B.S.G., R.A.K.), and the Center for Vaccine Development, University of Maryland School of Medicine, Baltimore (M.M.L.) - both in Maryland; and Keires, Basel, Switzerland (R.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1411627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798586PMC
April 2016

Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort.

Lancet Infect Dis 2015 Oct 4;15(10):1117-1119. Epub 2015 Aug 4.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(15)00222-4DOI Listing
October 2015

AS03-adjuvanted influenza vaccine in elderly people.

Lancet Infect Dis 2013 Jun 19;13(6):466-7. Epub 2013 Mar 19.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(13)70038-0DOI Listing
June 2013

Impact of viral attachment factor expression on antibody-mediated neutralization of flaviviruses.

Virology 2013 Mar 10;437(1):20-7. Epub 2013 Jan 10.

Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institute of Allergy & Infectious Diseases, NIH, Bethesda, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2012.11.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601793PMC
March 2013

Randomization to standard and concise informed consent forms: development of evidence-based consent practices.

Contemp Clin Trials 2012 Sep 20;33(5):895-902. Epub 2012 Apr 20.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-3017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2012.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408575PMC
September 2012

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.

Lancet Infect Dis 2011 Dec 3;11(12):916-24. Epub 2011 Oct 3.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(11)70240-7DOI Listing
December 2011

Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.

J Virol 2011 Sep 29;85(17):8954-67. Epub 2011 Jun 29.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00754-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165784PMC
September 2011

Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.

Travel Med Infect Dis 2011 May 26;9(3):126-34. Epub 2010 Jun 26.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 40 Convent Drive, Bethesda, MD 20892-3017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tmaid.2010.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116067PMC
May 2011

Vaccinate for the next H2N2 pandemic now.

Nature 2011 Mar;471(7337):157-8

Vaccine Research Center, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/471157aDOI Listing
March 2011

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses.

PLoS One 2010 Feb 2;5(2):e9015. Epub 2010 Feb 2.

Vaccine Research Center, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009015PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814848PMC
February 2010

DNA vaccines: a safe and efficient platform technology for responding to emerging infectious diseases.

Hum Vaccin 2009 Sep;5(9):623-6

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Heath, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.8627DOI Listing
September 2009